Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers ...Middle East

PHOENIX, Nov. 4, 2020 /PRNewswire/ -- Amnio Technology, LLC, a global leader in the development and distribution of amniotic tissue allografts, is announcing today that it has received authorization from FDA to proceed with a Phase 2 clinical trial under an Investigational New Drug (IND)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers )

Also on site :

• Japan starts deploying Osprey fleet at a new base to beef up southwestern defense
• South Africa seeks US trade deal after Trump’s 30% citrus tariff
• Josh O’Connor Goes Full Cowboy in ‘Rebuilding’ as Director Max Walker-Silverman Takes on Life After the Fires: ‘Loss Often Comes With Love’